Nutriband Inc. (NASDAQ:NTRBW – Get Free Report) shares traded down 5% during mid-day trading on Thursday . The stock traded as low as $0.80 and last traded at $1.33. 210 shares traded hands during trading, a decline of 97% from the average session volume of 6,697 shares. The stock had previously closed at $1.40.
Nutriband Price Performance
The stock has a 50-day moving average of $1.87 and a 200 day moving average of $1.91.
Hedge Funds Weigh In On Nutriband
A hedge fund recently bought a new stake in Nutriband stock. Clear Street Group Inc. purchased a new position in shares of Nutriband Inc. (NASDAQ:NTRBW – Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 61,590 shares of the company’s stock, valued at approximately $105,000.
Nutriband Company Profile
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
Read More
- Five stocks we like better than Nutriband
- 3 Best Fintech Stocks for a Portfolio Boost
- The Trade Desk: After a 70% Plunge, This Could Be The Time to Buy
- What Are Dividend Champions? How to Invest in the Champions
- Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF
- The Basics of Support and Resistance
- Strong Quarter, Weak Reaction: Why GitLab Shares Dropped
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
